Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank33
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-14.17M
↑ 32% vs avg
Percentile
P33
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-20.98M
Historical baseline
PeriodValueYoY Change
TTM$-14.17M+26.5%
2025$-19.27M+75.5%
2024$-78.76M+23.6%
2023$-103.15M-21.7%
2022$-84.78M-21.1%
2021$-70.00M-1087.5%
2020$7.09M-90.1%
2019$71.42M+144.4%
2018$29.22M-44.5%
2017$52.65M-